The oncoplot of tumor somatic mutation in the TCGA-LUAD cohort showed that TP53, TTN, and MUC16 gene mutations in the high-TMEscore group were approximately 20% higher than those in the low TMEscore group (Figures 5A and B). Here, MUC16 is linked to neoplasm.